Beschreibung:
<jats:title>Abstract</jats:title><jats:p>Short proline‐rich antimicrobial peptides (PrAMPs) are a promising class of antibiotics that use novel mechanisms, thus offering the potential to overcome the health threat of multiresistant pathogens. The peptides bind to the bacterial 70S ribosome and can inhibit protein translation. We report that PrAMPs can be divided into two classes, with each class binding to a different site, and thus use different lethal mechanisms. Oncocin‐type peptides inhibit protein translation in <jats:italic>Escherichia coli</jats:italic> by binding to the exit tunnel of the 70S ribosome with half maximal inhibitory concentrations (IC<jats:sub>50</jats:sub> values) of around 2 to 6 μmol L<jats:sup>−1</jats:sup>, whereas apidaecin‐type peptides block the assembly of the large (50S) subunit of the ribosome, resulting in similar IC<jats:sub>50</jats:sub> values. The revealed mechanisms should allow the design of new antibiotics to overcome current bacterial resistance mechanisms.</jats:p>